by Samuel May 27,2025
In a surprising twist, the indie game Schedule I, a co-op crime simulation where players climb the ranks from a small-time dope pusher to a kingpin, has been accused of copyright infringement by Movie Games S.A., the developers behind the The Drug Dealer Simulator series. According to a report by the Polish Press Agency on April 3, Movie Games S.A. concluded that Schedule I may have infringed on their intellectual property by borrowing plot elements, game mechanics, and even the user interface from their titles.
Despite the ongoing investigation, fans have taken sides, and it appears that Schedule I enjoys stronger support. In a remarkable turn of events, both The Drug Dealer Simulator and Drug Dealer Simulator 2 have faced a barrage of negative reviews on Steam, now labeled as "Overwhelmingly Negative" and "Mostly Negative" respectively. The recent reviews criticize Movie Games S.A. for what is perceived as bullying an indie developer and highlight the company's apparent hypocrisy, given that similar titles existed prior to Schedule I without facing legal challenges.
This backlash is notable, especially since the Drug Dealer Simulator series has been praised as one of the best criminal management games by various outlets and fans. Meanwhile, Schedule I, released for Early Access on PC on March 25, has garnered "Overwhelmingly Positive" reviews on Steam and currently ranks as the platform's 2nd top-selling game. It has surpassed popular titles like inZOI, Monster Hunter Wilds, and another indie game, R.E.P.O., with an all-time peak of 459,075 concurrent players according to SteamDB.
At Game8, we found Schedule I to be a surprisingly addictive and rewarding experience, earning it the nickname "Breaking Bad" simulator. For more insights on our thoughts about Schedule I's early access release, be sure to check out our detailed review below!


Indie dope pushing simulator title Schedule I has been accused of copyright infringement by Movie Games S.A., the developers of The Drug Dealer Simulator series. As published by the Polish Press Agency on April 3, Movie Games S.A. has finished their legal analysis and concluded that Schedule I may have violated The Drug Dealer Simulator IP rights. Based on their investigation, Schedule I used their games’ plot, mechanics, and even their user interface.

Despite nothing officially coming out of the investigation yet, fans have already sided with either of the titles, but it seems like Schedule I has more supporters. The Drug Dealer Simulator and Drug Dealer Simulator 2 have received multiple negative reviews on Steam, which are now tagged as "Overwhelmingly Negative" and "Mostly Negative" respectively.
Most of the recent reviews they received revolve around Movie Games S.A.’s bullying of the indie developer and their hypocrisy, as there were also previous titles of the same likeness to their game, yet were never called out until Schedule I’s release. This backlash comes despite the series being considered as one of the best criminal management games by different outlets and fans alike.
Zenless Zone Zero Update Cycle Leak Hints at Future Content cadence
All Mavuika Materials, Kit, and Constellations in Genshin Impact
Counterfeit Bank Simulator: Minting Solution for Economic Crises
Marvel Rivals: Season 1 Dracula Explained
Best Xbox Game Pass Games For Kids (January 2025)
Solo Leveling: Global Tournament Draws Near
Power Rangers: Uncover Hidden Secrets in Rita's Carnival and Cemetery
Roblox: Anime Auras RNG Codes (January 2025)
Impossible GT Stunt Sports Car
Download
Bar Abierto Caça Niquel
Download
Crossword Islands
Download
My Taco Shop: Food Game
Download
4Play - Mau Binh Online
Download
Word Games: Sex Word Puzzle
Download
VEGA - Game danh bai doi thuong
Download
Offline Mini Games All in One
Download
WOW: Dalam Bahasa Indonesia
Download
Donkey Kong Amiibo Preorders Open Now
Dec 22,2025
Honor of Kings to Join 2025 Esports World Cup
Dec 22,2025
Konami Celebrates Silent Hill 2 Remake Milestone of 2 Million Sales
Dec 21,2025
"Pokémon Go Launches Might & Mastery Season Tomorrow"
Dec 21,2025
Top Eleven 2026 Launches with Campus, Stadium & Fans
Dec 21,2025